Articles by William Looney - Pharmaceutical Executive


Articles by William Looney

What Makes an Emerging Pharma Leader

Aug 14, 2013

Editorial Director William Looney discusses the five essential characteristics exhibited by the more than 200 men and women selected by Pharmaceutical Executive as Emerging Pharma Leaders

Breaching the Great Wall

Aug 1, 2013

With a revision of China's basic drug approval law now underway, a multinational team of experts is proposing major changes to make the country a world class player in innovation.

One Company—One Moment

Aug 1, 2013

The trade media is ablaze with lurid accounts of bribery, tax fraud, and other illicit promotional activities in China—ironically, the country touted as guarantor of our industry's future.

Succinctly Shire: CEO Flemming Ornskov

Aug 1, 2013

Shire's new CEO has a simple strategy for success: Set the pace on specialty medicines, spread the positive buzz and momentum of a growth stock, and seize the opportunity to innovate.

Talent, Terror, and the Turnaround

Jul 1, 2013

Our lead feature this month on 15 new Emerging Pharma Leaders is a window into what makes our publication unique. In 2007, Pharm Exec began a systematic annual search to identify and highlight those men—and women—that in our purely editorial view had real prospects for a future key to the "c suite." Two of our early choices—Sanofi's Chris Viehbacher and Heather Bresch of Mylan—have made it to the very top, as CEO.

Recognizing the Best

Jun 1, 2013

Getting patients to take their medicine on spec and on time is the challenge that never goes away—it's the deadweight baggage accompanying every industry innovation since the arrival of aspirin a century ago.

The Patent Black Label

May 1, 2013

Last month's decision by India's Supreme Court to deny a patent for the top-selling oncologic drug Glivec took nearly a decade of litigation to resolve—but the implications in and beyond India are both immediate and lasting.

The Friendly Persuasion — An Interview with Fred Hassan

May 1, 2013

What is industry icon Fred Hassan's management formula for staying fresh in an era of market churn?

2013 Dealmakers Outlook

Apr 1, 2013

Pharm Exec's annual look at the trends and best practices in biopharm licensing and M&A for the year ahead.


Click here